Cherry Biotech team is coming to Oxford Discovery US 2024, an event that brings together key innovators in drug discovery and preclinical development and we are proud to be a sponsor of the event and having this chance to connect with great minds and thought leaders in the industry, and showcasing our cutting-edge innovation – the CubiX platform.
Details of our participation:
- Event: Oxford Discovery US 2024
- Location: Booth 08, Boston Marriott Cambridge, Boston, MA (US)
- When to book an appointment with our team:
November 7th-8th during the event, and November 9th – 14th 2024 – meeting on demand (our team will be meeting with pharmaceutical clients and biotech partners, so don’t miss this chance! - Cherry Biotech ‘s representatives:
- Jeremy Cramer – Cofounder & CEO.
- Pierre Gaudriault – Scientific Chief Business Developer, late founder.
- What we will present:
We specialize in complex 3D cell culture solutions, including immunocompetent organoids and vascularized tissue equivalents, aimed at helping biotech and pharma companies:- Accelerate time to clinic and market
- Increase the chances of success in clinical phase 2 (efficacy)
- Select and invest only in the most promising compounds
We are excited to meet with you during this period to discuss your current preclinical challenges and explore how we can collaborate.
Book an appointment through the contact form ➡️, and let’s find a time to connect!
